HPV E6 regulates therapy responses in oropharyngeal cancer by repressing the PGC-1α/ERRα axis
Therapy with radiation plus cisplatin kills HPV+ oropharyngeal squamous cell carcinomas (OPSCCs) by increasing reactive oxygen species beyond cellular antioxidant capacity. To explore why these standard treatments fail for some patients, we evaluated whether the variation in HPV oncoprotein levels a...
I tiakina i:
| Ngā kaituhi matua: | , , , , , , , , , , , , , , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
American Society for Clinical investigation
2022-09-01
|
| Rangatū: | JCI Insight |
| Ngā marau: | |
| Urunga tuihono: | https://doi.org/10.1172/jci.insight.159600 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|
